fashion -WSS

fashion

author：knowledge 2025-09-27 12:13:15 - browse：147

Eli Lilly headquarters — Kristoffer Tripplaar/AP

The drug giant Eli Lilly said Thursday that its diabetes drug Mounjaro helped patients with the condition lose 15.7% of their body weight in a clinical trial, a result that Wall Street analysts expect to pave the way for the therapy’s approval as a weight loss treatment.

Mounjaro is the latest drug in a class known as GLP-1s or incretins — the same class as Novo Nordisk’s Ozempic, which has become a sensation because of its ability to help patients lose weight. Mounjaro has shown the potential to lead to even greater weight loss than Ozempic, and industry experts expect that it will eventually generate many billions of dollars in annual sales. Analysts at SVB Securities projected in December that Mounjaro sales could reach $26.4 billion by 2030.

Eli Lilly on Thursday also announced quarterly earnings of $1.64 per share, adjusted for one-time items, slightly below analyst expectations, on sales of $6.96 billion. Sales were hurt because of a comparison to a year ago, when the company’s Covid-19 monoclonal antibodies were still on the market. Mounjaro sales for the first quarter were $586 million, largely for people with diabetes, compared to an analyst consensus of $433.2 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Life science postdocs should get big pay hike, NIH panel says

hotspot

WSS

In shift, Texas to cover initial consult for Afghan baby's gene therapy

US judge blocks portions of new Florida elections law

Churchill Downs extends trainer Bob Baffert's ban through 2024

Does Paxlovid work in people vaccinated against Covid

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

leisure time

fashion

Wikipedia

DIEP, the 'gold standard' of breast reconstruction, is under threat

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

Peter Hotez and the public health issue of online harassment

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

The cancer drug shortage isn’t new — and neither are the solutions

JPM pitch from hospitals? Revenue streams outside of patient care

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Life science postdocs should get big pay hike, NIH panel says

The cancer drug shortage isn’t new — and neither are the solutions

Ascension's ugly legal battle over care for poor patients in Texas

focus

NASA releases new images of 'fingerprint

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

NASA releases new images of 'fingerprint

PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works

1 dead, 9 hurt in July 4th fireworks explosion

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

hotspot

hotspot

Wikipedia

knowledge